Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Gross Margin
Qingdao Baheal Medical Inc

30.3%
Current
27%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.3%
=
Gross Profit
2.3B
/
Revenue
7.5B

Gross Margin Across Competitors

Country CN
Market Cap 14.3B CNY
Gross Margin
30%
Country US
Market Cap 77.7B USD
Gross Margin
4%
Country US
Market Cap 48.6B USD
Gross Margin
3%
Country US
Market Cap 48.4B USD
Gross Margin
3%
Country US
Market Cap 30.3B USD
Gross Margin
3%
Country US
Market Cap 9.3B USD
Gross Margin
32%
Country CN
Market Cap 65.2B CNY
Gross Margin
32%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Country CN
Market Cap 64.3B HKD
Gross Margin
8%
Country CN
Market Cap 60.5B CNY
Gross Margin
11%
Country IT
Market Cap 5.5B EUR
Gross Margin
24%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
30.3%
=
Gross Profit
2.3B
/
Revenue
7.5B
What is the Gross Margin of Qingdao Baheal Medical Inc?

Based on Qingdao Baheal Medical Inc's most recent financial statements, the company has Gross Margin of 30.3%.